Records containing: Neuroendocrine Tumor
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-11-12Evaluation of Gallium-68 DOTA-TOC Imaging of Somatostatin Receptor Positive Malignancies
-
CLINICAL_TRIALS study record update · 2019-07-23A Pilot Study Utilizing Molecular Analysis Via Cancer CodeTM to Identify Therapeutic Targets for Patients With Advanced Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2017-12-27A Multi-Institutional, Phase II Open-Label Study of AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2016-10-19Phase I Study of Pasireotide (SOM230) in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2016-06-2190Y-DOTA-tyr3-Octreotide With or Without Retinoic Acid for the Treatment of Neuroblastoma and Neuroendocrine Tumors in Children and Young Adults. A Randomized, Placebo Controlled Phase II Trial With Dosimetry Guided Dosing
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-04-28Phase III Prospective Randomized Comparison of Depot Octreotide Plus Interferon Alpha Versus Depot Octreotide Plus Bevacizumab (NSC #704865) in Advanced, Poor Prognosis Carcinoid Patients
-
CLINICAL_TRIALS study record update · 2015-12-29Phase II Study of Pazopanib Monotherapy in Patients With Unresectable, Metastatic Neuroendocrine Tumor
-
CLINICAL_TRIALS study record update · 2014-11-17A Phase II Trial of Bay 43-9006 in Progressive Metastatic Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2014-04-29Phase I Study of Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2014-01-1768Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2012-09-18ClinicalTrials.gov study NCT01448083
-
CLINICAL_TRIALS study record update · 2012-09-07Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization for Metastatic Gastrointestinal Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2012-03-30An Open Label, Stratified, Single-arm Phase II Study of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumor (NET) After Failure of Cytotoxic Chemotherapy
-
CLINICAL_TRIALS study record update · 2010-10-26Gastrointestinal Motility in Patients With Neuroendocrine Tumors-Effects of Sandostatin LAR
-
CLINICAL_TRIALS study record update · 2009-04-28A Phase II Study of Thalidomide in Combination With Temodar in Patients With Metastatic Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2009-02-17Ga68-DOTA-NOC-PET Imaging of Neuroendocrine Tumors